FDA approves Gilead HIV drug NDA
Aptalis Pharma and Gilead have co-developed the oral powder formulation of Viread using the Aptalis Microcaps taste-masking technology. The Aptalis microencapsulation technology, known as Microcaps, employs versatile and
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.